Compounds and compositions for the inhibition of NAMPT
US-12336981-B2 · Jun 24, 2025 · US
This page is not indexed by search engines while we improve data quality.
Smith Chase C patents
Smith Chase C is listed as an inventor on 26 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Smith Chase C |
| Total patents | 26 |
| First publication | Dec 28, 2017 |
| Latest publication | Jun 24, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators
US-12071440-B2 · Aug 27, 2024 · US
Treating sickle cell disease with a pyruvate kinase R activating compound
US-12053458-B2 · Aug 6, 2024 · US
Treating sickle cell disease with a pyruvate kinase R activating compound
US-11980611-B2 · May 14, 2024 · US
Pyrrolopyrrole compositions as pyruvate kinase (pkr) activators
US-2024083901-A1 · Mar 14, 2024 · US
Treating sickle cell disease with a pyruvate kinase r activating compound
US-2023381151-A1 · Nov 30, 2023 · US
Novel compounds and compositions for the inhibition of nampt
US-2023346753-A1 · Nov 2, 2023 · US
Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators
US-11649242-B2 · May 16, 2023 · US
Compounds and compositions for the inhibition of NAMPT
US-11547701-B2 · Jan 10, 2023 · US
Compounds and compositions for the inhibition of NAMPT
US-11279687-B2 · Mar 22, 2022 · US
Recent patents
Latest publications not already listed above.
Pyrrolopyrrole compositions as pyruvate kinase (pkr) activators
US-2021246143-A1 · Aug 12, 2021 · US
Novel compounds and compositions for the inhibition of nampt
US-2021244717-A1 · Aug 12, 2021 · US
Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators
US-11014927-B2 · May 25, 2021 · US
Compounds and compositions for the inhibition of NAMPT
US-10772874-B2 · Sep 15, 2020 · US
Novel compounds and compositions for the inhibition of nampt
US-2020283403-A1 · Sep 10, 2020 · US
Amido-benzyl sulfone and sulfoxide derivates
US-10696692-B2 · Jun 30, 2020 · US
Compounds and compositions for the inhibition of NAMPT
US-10647695-B2 · May 12, 2020 · US
Pyrrolopyrrole compositions as pyruvate kinase (pkr) activators
US-2020069643-A1 · Mar 5, 2020 · US
Novel compounds and compositions for the inhibition of nampt
US-2019388405-A1 · Dec 26, 2019 · US
Compounds and compositions for the inhibition of NAMPT
US-10456382-B2 · Oct 29, 2019 · US
Novel compounds and compositions for the inhibition of nampt
US-2019270721-A1 · Sep 5, 2019 · US
Compounds and compositions for the inhibition of NAMPT
US-10329275-B2 · Jun 25, 2019 · US
Compounds and compositions for the inhibition of NAMPT
US-10272072-B2 · Apr 30, 2019 · US
Novel compounds and compositions for the inhibition of nampt
US-2019105307-A1 · Apr 11, 2019 · US
Novel compounds and compositions for the inhibition of nampt
US-2018291000-A1 · Oct 11, 2018 · US
Novel compounds and compositions for the inhibition of nampt
US-2017368039-A1 · Dec 28, 2017 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Genentech Inc | 17 |
| Forma Tm Llc | 12 |
| Forma Therapeutics Inc | 6 |
| Valo Health Inc | 4 |
| Novo Nordisk Healthcare Ag | 3 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07D487/04 | 20 |
| A61P9/10 | 17 |
| A61P3/10 | 17 |
| A61P35/02 | 17 |
| A61P35/00 | 17 |